回肠巨大原发性弥漫性大B细胞淋巴瘤合并肠梗阻1例
A Case of Primary Diffuse Large B Cell Lymphoma of the Giant Ileum Complicated with Intestinal Obstruction
摘要: 目的:本文旨在探讨回肠巨大原发性弥漫性大B细胞淋巴瘤的临床表现、影像学特点及诊治要点。方法:对延安市人民医院胃肠外科收治的回肠巨大原发性弥漫性大B细胞淋巴瘤合并肠梗阻1例患者进行病例回顾并复习相关文献。结果:回肠巨大原发性弥漫性大B细胞淋巴瘤,发病率低,临床表现不典型;合并肠梗阻者,往往容易误诊及漏诊,最终确诊要需手术探查及病理。结论:回肠原发性弥漫性大B细胞淋巴瘤合并肠梗阻缺乏特异性临床表现,手术为首选治疗方法,需结合手术病理及免疫组化进行确诊。
Abstract: Objective: To explore the clinical manifestations, imaging characteristics, and key points of diagnosis and treatment of giant primary diffuse large B-cell lymphoma in the ileum. Method: A case review and literature review were conducted on a patient with giant primary diffuse large B-cell lymphoma of the ileum and intestinal obstruction admitted to the Department of Gastroenterology at Yan’an People’s Hospital. Results: The large primary diffuse large B-cell lymphoma of the ileum had a low incidence rate and atypical clinical manifestations; Patients with combined intestinal obstruction are often prone to misdiagnosis and missed diagnosis, and the final diagnosis requires surgical exploration and pathology. Conclusion: Primary diffuse large B-cell lymphoma of the ileum with intestinal obstruction lacks specific clinical manifestations, and surgery is the preferred treatment method. Diagnosis should be based on surgical pathology and immunohistochemistry.
文章引用:程鑫瀚, 李盼. 回肠巨大原发性弥漫性大B细胞淋巴瘤合并肠梗阻1例[J]. 临床个性化医学, 2024, 3(3): 858-862. https://doi.org/10.12677/jcpm.2024.33124

参考文献

[1] Ghimire, P. (2011) Primary Gastrointestinal Lymphoma. World Journal of Gastroenterology, 17, 697-707. [Google Scholar] [CrossRef] [PubMed]
[2] 刘静, 焦俊, 张英俊, 等. 小肠肠壁增厚的多层螺旋CT小肠造影征象分析和诊断价值[J]. 临床放射学杂志, 2015, 34(12): 1919-1923.
[3] Dawson, I.M.P., Cornes, J.S. and Morson, B.C. (1961) Primary Malignant Lymphoid Tumours of the Intestinal Tract. Report of 37 Cases with a Study of Factors Influencing Prognosis. British Journal of Surgery, 49, 80-89. [Google Scholar] [CrossRef] [PubMed]
[4] Warrick, J., Luo, J., Robirds, D., Branson, J., Frater, J.L., Kreisel, F., et al. (2012) Gastrointestinal Lymphomas in a North American Population: Clinicopathologic Features from One Major Central-Midwestern United States Tertiary Care Medical Center. Diagnostic Pathology, 7, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
[5] Li, B., Shi, Y., He, X., Zou, S., Zhou, S., Dong, M., et al. (2008) Primary Non-Hodgkin Lymphomas in the Small and Large Intestine: Clinicopathological Characteristics and Management of 40 Patients. International Journal of Hematology, 87, 375-381. [Google Scholar] [CrossRef] [PubMed]
[6] De Paepe, P., Achten, R., Verhoef, G., Wlodarska, I., Stul, M., Vanhentenrijk, V., et al. (2005) Large Cleaved and Immunoblastic Lymphoma May Represent Two Distinct Clinicopathologic Entities within the Group of Diffuse Large B-Cell Lymphomas. Journal of Clinical Oncology, 23, 7060-7068. [Google Scholar] [CrossRef] [PubMed]
[7] Ottensmeier, C.H. and Stevenson, F.K. (2000) Isotype Switch Variants Reveal Clonally Related Subpopulations in Diffuse Large B-Cell Lymphoma. Blood, 96, 2550-2556. [Google Scholar] [CrossRef
[8] 邓宁, 胡庆芬, 张珑维. 小肠原发性弥漫性大B细胞型非霍奇金淋巴瘤致小肠机械性肠梗阻,回肠-回肠肠套叠1例[J]. 中国社区医师, 2019, 35(18): 17-18.
[9] Ottensmeier, C.H. and Stevenson, F.K. (2000) Isotype Switch Variants Reveal Clonally Related Subpopulations in Diffuse Large B-Cell Lymphoma. Blood, 96, 2550-2556. [Google Scholar] [CrossRef
[10] Cheson, B.D. and Leonard, J.P. (2008) Monoclonal Antibody Therapy for B-Cell Non-Hodgkin’s Lymphoma. New England Journal of Medicine, 359, 613-626. [Google Scholar] [CrossRef] [PubMed]
[11] Pfreundschuh, M., Kuhnt, E., Trümper, L., Österborg, A., Trneny, M., Shepherd, L., et al. (2011) Chop-Like Chemotherapy with or without Rituximab in Young Patients with Good-Prognosis Diffuse Large-B-Cell Lymphoma: 6-Year Results of an Open-Label Randomised Study of the Mabthera International Trial (MInT) Group. The Lancet Oncology, 12, 1013-1022. [Google Scholar] [CrossRef] [PubMed]
[12] 林桐榆, 张红雨, 黄岩, 等. R-CHOP与CHOP方案治疗初治弥漫大B细胞型淋巴瘤在中国的多中心随机对照研究[J]. 癌症, 2005, 24(12): 1421-1426.